
### [NCIT:C7587](http://purl.obolibrary.org/obo/NCIT_C7587)
**Label:** Adult Lymphoma

**Subclasses:** [NCIT:C7704](http://purl.obolibrary.org/obo/NCIT_C7704) (Adult Non-Hodgkin Lymphoma), [NCIT:C7942](http://purl.obolibrary.org/obo/NCIT_C7942) (Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C7226](http://purl.obolibrary.org/obo/NCIT_C7226) (Adult T Lymphoblastic Lymphoma), [NCIT:C114784](http://purl.obolibrary.org/obo/NCIT_C114784) (Non-Hodgkin Lymphoma During Pregnancy), [NCIT:C7702](http://purl.obolibrary.org/obo/NCIT_C7702) (Adult Hodgkin Lymphoma), [NCIT:C7789](http://purl.obolibrary.org/obo/NCIT_C7789) (Recurrent Adult Hodgkin Lymphoma), [NCIT:C9127](http://purl.obolibrary.org/obo/NCIT_C9127) (Adult Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8159](http://purl.obolibrary.org/obo/NCIT_C8159) (Recurrent Adult Burkitt Lymphoma), [NCIT:C7223](http://purl.obolibrary.org/obo/NCIT_C7223) (Adult Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C114783](http://purl.obolibrary.org/obo/NCIT_C114783) (Hodgkin Lymphoma During Pregnancy), [NCIT:C9125](http://purl.obolibrary.org/obo/NCIT_C9125) (Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C115154](http://purl.obolibrary.org/obo/NCIT_C115154) (Adult Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C8078](http://purl.obolibrary.org/obo/NCIT_C8078) (Stage I Adult Immunoblastic Lymphoma), [NCIT:C8079](http://purl.obolibrary.org/obo/NCIT_C8079) (Stage I Adult Lymphoblastic Lymphoma), [NCIT:C115150](http://purl.obolibrary.org/obo/NCIT_C115150) (Adult Grade III Lymphomatoid Granulomatosis), [NCIT:C8482](http://purl.obolibrary.org/obo/NCIT_C8482) (Stage III Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C9252](http://purl.obolibrary.org/obo/NCIT_C9252) (Stage I Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C8163](http://purl.obolibrary.org/obo/NCIT_C8163) (Recurrent Adult Immunoblastic Lymphoma), [NCIT:C8080](http://purl.obolibrary.org/obo/NCIT_C8080) (Stage I Adult Burkitt Lymphoma), [NCIT:C27366](http://purl.obolibrary.org/obo/NCIT_C27366) (Adult Systemic Anaplastic Large Cell Lymphoma), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C27367](http://purl.obolibrary.org/obo/NCIT_C27367) (Adult Anaplastic Large Cell Lymphoma), [NCIT:C8126](http://purl.obolibrary.org/obo/NCIT_C8126) (Stage II Adult Burkitt Lymphoma), [NCIT:C8124](http://purl.obolibrary.org/obo/NCIT_C8124) (Stage II Adult Immunoblastic Lymphoma), [NCIT:C8487](http://purl.obolibrary.org/obo/NCIT_C8487) (Stage IV Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C7873](http://purl.obolibrary.org/obo/NCIT_C7873) (Adult Immunoblastic Lymphoma), [NCIT:C8488](http://purl.obolibrary.org/obo/NCIT_C8488) (Recurrent Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C8125](http://purl.obolibrary.org/obo/NCIT_C8125) (Stage II Adult Lymphoblastic Lymphoma), [NCIT:C8485](http://purl.obolibrary.org/obo/NCIT_C8485) (Stage IV Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C8164](http://purl.obolibrary.org/obo/NCIT_C8164) (Recurrent Adult Lymphoblastic Lymphoma), [NCIT:C8484](http://purl.obolibrary.org/obo/NCIT_C8484) (Stage III Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C8492](http://purl.obolibrary.org/obo/NCIT_C8492) (Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C9062](http://purl.obolibrary.org/obo/NCIT_C9062) (Adult Burkitt Lymphoma), [NCIT:C8490](http://purl.obolibrary.org/obo/NCIT_C8490) (Recurrent Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C8491](http://purl.obolibrary.org/obo/NCIT_C8491) (Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C69138](http://purl.obolibrary.org/obo/NCIT_C69138) (Adult Classical Hodgkin Lymphoma), [NCIT:C68688](http://purl.obolibrary.org/obo/NCIT_C68688) (Stage II Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C68686](http://purl.obolibrary.org/obo/NCIT_C68686) (Stage II Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C8139](http://purl.obolibrary.org/obo/NCIT_C8139) (Stage III Adult Burkitt Lymphoma), [NCIT:C8137](http://purl.obolibrary.org/obo/NCIT_C8137) (Stage III Adult Immunoblastic Lymphoma), [NCIT:C8138](http://purl.obolibrary.org/obo/NCIT_C8138) (Stage III Adult Lymphoblastic Lymphoma), [NCIT:C8098](http://purl.obolibrary.org/obo/NCIT_C8098) (Recurrent Adult Non-Hodgkin Lymphoma), [NCIT:C9032](http://purl.obolibrary.org/obo/NCIT_C9032) (Stage I Adult Hodgkin Lymphoma), [NCIT:C7615](http://purl.obolibrary.org/obo/NCIT_C7615) (Adult Diffuse Large B-Cell Lymphoma), [NCIT:C115349](http://purl.obolibrary.org/obo/NCIT_C115349) (Recurrent Adult Grade III Lymphomatoid Granulomatosis), [NCIT:C7338](http://purl.obolibrary.org/obo/NCIT_C7338) (Adult B Lymphoblastic Lymphoma), [NCIT:C8104](http://purl.obolibrary.org/obo/NCIT_C8104) (Stage III Adult Non-Hodgkin Lymphoma), [NCIT:C8105](http://purl.obolibrary.org/obo/NCIT_C8105) (Stage IV Adult Non-Hodgkin Lymphoma), [NCIT:C8102](http://purl.obolibrary.org/obo/NCIT_C8102) (Stage I Adult Non-Hodgkin Lymphoma), [NCIT:C8103](http://purl.obolibrary.org/obo/NCIT_C8103) (Stage II Adult Non-Hodgkin Lymphoma), [NCIT:C9035](http://purl.obolibrary.org/obo/NCIT_C9035) (Stage IV Adult Hodgkin Lymphoma), [NCIT:C8464](http://purl.obolibrary.org/obo/NCIT_C8464) (Stage I Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C9033](http://purl.obolibrary.org/obo/NCIT_C9033) (Stage II Adult Hodgkin Lymphoma), [NCIT:C9034](http://purl.obolibrary.org/obo/NCIT_C9034) (Stage III Adult Hodgkin Lymphoma), [NCIT:C9361](http://purl.obolibrary.org/obo/NCIT_C9361) (Adult Lymphoblastic Lymphoma), [NCIT:C8151](http://purl.obolibrary.org/obo/NCIT_C8151) (Stage IV Adult Lymphoblastic Lymphoma), [NCIT:C8152](http://purl.obolibrary.org/obo/NCIT_C8152) (Stage IV Adult Burkitt Lymphoma), [NCIT:C8150](http://purl.obolibrary.org/obo/NCIT_C8150) (Stage IV Adult Immunoblastic Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 40.36%


